Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $127.58 million versus the consensus estimate of $130.03 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.